| Patient | Martin Luther King |
|---|---|
| Date of birth | 1990-01-15 |
| Identifiers | MRN HR-ML001-SYN; SSN (made up) 000-01-4058 |
| Document date | 2026-11-01 |
| Author | Cornelius Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for exhaustion, poor sleep and low mood: history, examination, ECG, blood tests, depression, anxiety, PTSD and safety screening, tobacco and blood pressure assessment, and a psychiatry referral. Concerns: He is exhausted and sleeps badly, and fears that if he slows down the movement will lose ground; He worries that a psychiatric diagnosis or medicine could be used against him and the movement, and wants his records kept private; He wants to stop smoking before his children see him smoke. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg tablet, one by mouth once daily for 3 days, then twice daily for 4 days | once daily for 3 days, then twice daily for 4 days, after food | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Varenicline 1 mg tablet, one by mouth twice daily after food | twice daily after food | Oral route | 2026-05-19 | active | S |
| Acetaminophen 500 mg tablet, one or two by mouth every 6 hours as needed for chest-wall aching with the cough, no more than 3,000 mg a day | every 6 hours as needed, at most 3,000 mg a day | Oral route | 2026-08-04 to 2026-08-18 | completed | S |
| Sertraline 25 mg tablet, one by mouth each morning for one week | once daily in the morning | Oral route | 2026-04-20 to 2026-04-27 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 2026-04-27 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Resting twelve-lead electrocardiogram | 2026-04-07 to 2026-04-07 | completed | S |
| Advance care planning conversation, about 18 minutes | 2026-05-12 to 2026-05-12 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-05-12 | Tdap vaccine | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| seven years ago | Stab wound of the upper left chest, close to the aorta, repaired at thoracic surgery seven years ago, with a full recovery over about five weeks | D (CLM-0007) |
| six months ago | Admission for several days' rest for exhaustion and a respiratory infection six months ago | D (CLM-0010) |
| age twelve | An impulsive act of self-injury in grief at twelve, after his grandmother's death; he has not described it as a suicide attempt | D (CLM-0003) |
| the past five years | Repeated arrests and jailings over the past five years, including two weeks in jail and a sentence of hard labor | D (CLM-0008) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He is exhausted and sleeps badly, and fears that if he slows down the movement will lose ground | active | S |
| He worries that a psychiatric diagnosis or medicine could be used against him and the movement, and wants his records kept private | active | S |
| He wants to stop smoking before his children see him smoke | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 14.8 on 2026-04-07; Leukocytes [#/volume] in Blood by Automated count 7.2 on 2026-04-07; Platelets [#/volume] in Blood by Automated count 250 on 2026-04-07; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-04-07; Potassium [Moles/volume] in Serum or Plasma 4.1 on 2026-04-07; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 2026-04-07; Urea nitrogen [Mass/volume] in Serum or Plasma 13 on 2026-04-07; Creatinine [Mass/volume] in Serum or Plasma 1.04 on 2026-04-07; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-04-07; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 on 2026-04-07; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-04-07; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-04-07; Cholesterol [Mass/volume] in Serum or Plasma 196 on 2026-09-15; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-09-15; Cholesterol in HDL [Mass/volume] in Serum or Plasma 45 on 2026-09-15; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 127 on 2026-09-15; Q-T interval corrected 412 on 2026-04-07; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 95 on 2026-04-07; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-09-15; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 2026-07-14; PC-PTSD-5 score [PC-PTSD-5] 1 on 2026-07-14; Total score [AUDIT-C] 2 on 2026-04-07; Albumin/Creatinine [Mass Ratio] in Urine 8 on 2026-06-02 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Exhaustion, broken sleep and low mood for about two months, under sustained threats and a punishing schedule, after an admission for exhaustion and a respiratory infection six months ago; cause not established at intake: a depressive disorder, an adjustment disorder, PTSD, an insomnia disorder, thyroid disease and anemia to be assessed; psychiatry consultation requested | resolved | confirmed | R53.83 | S — Synthetic presenting problem anchored to his documented admission for exhaustion and the threats against him; superseded by the diagnoses at the second visit. |
| Major depressive disorder, single episode, moderate (DSM-5-TR), arising under chronic threat, surveillance and overwork; no suicidal ideation; PTSD not present on screening and interview | active | confirmed | F32.1 | S — Synthetic modern diagnosis made at the psychiatry consultation, linked to his documented exhaustion and threats and to biographers' accounts of depression (R); not a claim that he was so diagnosed. |
| Insomnia disorder (DSM-5-TR), comorbid with depression: trouble falling and staying asleep at least four nights a week for over three months, with short sleep from late-night work and travel | active | confirmed | G47.00 | S — Synthetic modern diagnosis made at the psychiatry consultation. |
| Nicotine dependence, cigarettes: about a pack a day since his twenties, smoked out of public view | active | confirmed | F17.210 | S — Synthetic modern problem anchored to the documented account of his heavy, hidden smoking. |
| Elevated blood pressure readings in the clinic (138/88 mmHg) without a diagnosis of hypertension; home monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding; superseded by the diagnosis at the six-week visit. |
| Healed stab wound of the left chest, repaired by thoracotomy seven years ago; occasional aching along the scar with coughing and in cold weather, without exertional or ischemic features | active | confirmed | Z87.828 | S — Synthetic modern problem anchored to his documented stabbing and chest surgery in 1958. |
| Acute bronchitis after a cold, in a man eleven weeks off cigarettes; no pneumonia; managed without antibiotics; resolved | resolved | confirmed | J20.9 | S — Synthetic acute problem; not a historical claim. |
| Stage 1 hypertension (2017 ACC/AHA), confirmed by home readings averaging 136/86 mmHg; no end-organ damage (normal ECG, urine albumin, kidney function and fundi); low estimated 10-year risk; lifestyle treatment | active | confirmed | I10 | S — Synthetic modern diagnosis made at the eight-week visit; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-07 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-04-07 | Leukocytes [#/volume] in Blood by Automated count | 7.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-04-07 | Platelets [#/volume] in Blood by Automated count | 250 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-04-07 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-07 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-07 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-04-07 | Urea nitrogen [Mass/volume] in Serum or Plasma | 13 | mg/dL | 7-20 mg/dL | Normal | S |
| 2026-04-07 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-07 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-07 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-55 U/L | Normal | S |
| 2026-04-07 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-04-07 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | Below 5.7 | Normal | S |
| 2026-04-07 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | Below 200 | High | S |
| 2026-04-07 | Triglyceride [Mass/volume] in Serum or Plasma | 150 | mg/dL | Below 150 | High | S |
| 2026-04-07 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 42 | mg/dL | 40 or more | Normal | S |
| 2026-04-07 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 142 | mg/dL | Below 130 | High | S |
| 2026-04-07 | Q-T interval corrected | 412 | ms | Above 450 ms is prolonged in men | Normal | S |
| 2026-04-07 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 95 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-04-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 17 | {score} | S | ||
| 2026-04-07 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 11 | {score} | S | ||
| 2026-04-07 | PC-PTSD-5 score [PC-PTSD-5] | 2 | {score} | S | ||
| 2026-04-07 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 2026-05-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 13 | {score} | S | ||
| 2026-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | {score} | S | ||
| 2026-06-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 11 | {score} | S | ||
| 2026-06-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S | ||
| 2026-06-02 | Albumin/Creatinine [Mass Ratio] in Urine | 8 | mg/g | Below 30 | Normal | S |
| 2026-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-07-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 2026-07-14 | PC-PTSD-5 score [PC-PTSD-5] | 1 | {score} | S | ||
| 2026-09-15 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-09-15 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | Below 200 | Normal | S |
| 2026-09-15 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | Below 150 | Normal | S |
| 2026-09-15 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 45 | mg/dL | 40 or more | Normal | S |
| 2026-09-15 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 127 | mg/dL | Below 130 | Normal | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-07 | Body height | 170 | cm | S |
| 2026-04-07 | Body weight | 84 | kg | S |
| 2026-04-07 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 2026-04-07 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-04-07 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 2026-04-07 | Heart rate | 84 | /min | S |
| 2026-04-07 | Respiratory rate | 16 | /min | S |
| 2026-04-07 | Body temperature | 36.7 | Cel | S |
| 2026-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-04-20 | Body height | 170 | cm | S |
| 2026-04-20 | Body weight | 84.2 | kg | S |
| 2026-04-20 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 2026-04-20 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-04-20 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-04-20 | Heart rate | 80 | /min | S |
| 2026-04-20 | Respiratory rate | 14 | /min | S |
| 2026-04-20 | Body temperature | 36.6 | Cel | S |
| 2026-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-02 | Body height | 170 | cm | S |
| 2026-06-02 | Body weight | 84.6 | kg | S |
| 2026-06-02 | Body mass index (BMI) [Ratio] | 29.3 | kg/m2 | S |
| 2026-06-02 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-06-02 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-06-02 | Heart rate | 76 | /min | S |
| 2026-06-02 | Respiratory rate | 14 | /min | S |
| 2026-06-02 | Body temperature | 36.7 | Cel | S |
| 2026-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-07-14 | Body height | 170 | cm | S |
| 2026-07-14 | Body weight | 84 | kg | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 2026-07-14 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-07-14 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-07-14 | Heart rate | 72 | /min | S |
| 2026-07-14 | Respiratory rate | 14 | /min | S |
| 2026-07-14 | Body temperature | 36.6 | Cel | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-09-15 | Body height | 170 | cm | S |
| 2026-09-15 | Body weight | 82.8 | kg | S |
| 2026-09-15 | Body mass index (BMI) [Ratio] | 28.7 | kg/m2 | S |
| 2026-09-15 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-09-15 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-09-15 | Heart rate | 70 | /min | S |
| 2026-09-15 | Respiratory rate | 14 | /min | S |
| 2026-09-15 | Body temperature | 36.6 | Cel | S |
| 2026-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-05-12 | Body height | 170 | cm | S |
| 2026-05-12 | Body weight | 84.4 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 29.2 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 78 | /min | S |
| 2026-05-12 | Respiratory rate | 14 | /min | S |
| 2026-05-12 | Body temperature | 36.6 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-08-04 | Body height | 170 | cm | S |
| 2026-08-04 | Body weight | 83.4 | kg | S |
| 2026-08-04 | Body mass index (BMI) [Ratio] | 28.9 | kg/m2 | S |
| 2026-08-04 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-08-04 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-08-04 | Heart rate | 82 | /min | S |
| 2026-08-04 | Respiratory rate | 16 | /min | S |
| 2026-08-04 | Body temperature | 37.2 | Cel | S |
| 2026-08-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-04-07 | New patient visit for exhaustion, poor sleep and low mood: history, examination, ECG, blood tests, depression, anxiety, PTSD and safety screening, tobacco and blood pressure assessment, and a psychiatry referral | finished | S |
| 2026-04-20 | Two-week review and psychiatry consultation: diagnosis, safety, therapy and medicine | finished | S |
| 2026-06-02 | Eight-week review: mood, sleep, sertraline, smoking cessation and home blood pressure | finished | S |
| 2026-07-14 | Fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan | finished | S |
| 2026-09-15 | Twenty-three-week review: remission, smoking, blood pressure and lipids | finished | S |
| 2026-05-12 | Periodic adult preventive visit | finished | S |
| 2026-08-04 | Same-day sick visit for cough | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Psychiatry consultation in two weeks to confirm the diagnosis, assess for PTSD and safety, and advise on therapy and medicine | completed | GL-APA-DEP-2019, GL-PTSD-2023 | S |
| Assessment at intake: blood count, metabolic panel, TSH, lipids, hemoglobin A1c and ECG; PHQ-9, GAD-7, PC-PTSD-5 and AUDIT-C; Insomnia Severity Index and sleep apnea screening; safety plan with the 988 Suicide & Crisis Lifeline and the clinic number | completed | GL-CMID-2026, GL-SUICIDE-2024, GL-ACP-INSOMNIA-2016 | S |
| Tobacco: advice to quit, an offer of counseling and medicine, and a quit plan agreed by shared decision | completed | GL-USPSTF-TOB-2021 | S |
| Blood pressure: validated home monitoring, twice morning and evening for seven days, before a diagnosis is made | completed | GL-ACC-AHA-BP-2017, GL-USPSTF-HTN-2021, GL-CMID-2026 | S |
| Privacy: a restricted chart with audited access, documentation kept to what care requires, and a choice of therapist, including a Black clinician if he prefers | completed | GL-APA-DEP-2019 | S |
| Depression and insomnia: weekly cognitive behavioral therapy with CBT for insomnia (fixed rising time, a sleep window, no work in bed), respecting his faith; sertraline 25 mg daily for a week, then 50 mg, by shared decision; no hypnotic | completed | GL-APA-DEP-2019, GL-ACP-INSOMNIA-2016, GL-AASM-INSOMNIA-2021, GL-CMID-2026 | S |
| A sustainable work plan: one full day a week without work, no more than two speeches a day, delegation of travel and correspondence, and a two-week break in the summer | completed | GL-APA-DEP-2019 | S |
| Varenicline 0.5 mg daily for three days, twice daily for four days, then 1 mg twice daily for twelve weeks, with a quit date on day eight and weekly telephone counseling; mood and sleep watched | completed | GL-USPSTF-TOB-2021, GL-EAGLES-2016 | S |
| Stage 1 hypertension at low estimated risk: lifestyle treatment (sodium below 1,500 to 2,300 mg a day, DASH-style eating, 150 minutes of activity a week, weight loss, no tobacco), home readings, urine albumin and a fundus examination; medicine if home readings stay at or above 130/80 after three to six months | completed | GL-ACC-AHA-BP-2017, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Depression remission (PHQ-9 below 5) by six months | 2026-09-15 | completed | PHQ-9 4 at twenty-three weeks, from 17 | S |
| Sleep of at least six and a half hours on most nights, with an Insomnia Severity Index below 10 | 2026-09-15 | completed | About seven hours on most nights; ISI 7 at twenty-three weeks | S |
| Smoke-free, confirmed at every visit after the quit date | 2026-11-30 | active | Smoke-free since the quit date except one lapse in June; finishing a second twelve weeks of varenicline | S |
| Home blood pressure below 130/80 mmHg with lifestyle changes | 2026-12-31 | active | Home average 128/82 at twenty-three weeks, from 136/86 | S |
| A sustainable schedule: one full day a week without work, no more than two speeches a day, and a two-week break in the summer | 2026-07-14 | completed | Kept for six weeks; two-week break taken in July | S |
Structured synthetic safety assessment on 2026-04-07: current ideation absent, intent absent, plan absent. No suicidal ideation, intent, plan or past suicide attempt. He expects that he may be killed and has accepted the risk, which is a realistic appraisal, not a wish to die. Risk factors weighed: an impulsive act of self-injury in grief at twelve, an anonymous letter urging him to end his life, depression, insomnia and isolation of leadership. Outpatient care with a safety plan, the 988 Suicide & Crisis Lifeline and the clinic number, and review at every visit [S]